Dexcom (DXCM) Invested Capital (2010 - 2017)

Dexcom (DXCM) has 8 years of Invested Capital data on file, last reported at $75.0 million in Q1 2017.

• On a quarterly basis, Invested Capital rose 4311.76% year-over-year to $75.0 million in Q1 2017; TTM through Dec 2017 was $75.0 million, a 4311.76% increase from a year earlier, with the FY2015 full-year figure at $2.3 million, changed 0.0% from the prior year.
• Invested Capital for Q1 2017 stood at $75.0 million, up from $1.7 million in the prior quarter.
• Over the last five years, Invested Capital for DXCM reached as high as $75.0 million in Q1 2017 and fell as low as $700000.0 in Q1 2013.
• Historically, Invested Capital has averaged $7.2 million across 5 years, with a median of $2.3 million in 2014.
• Across the five-year window, Invested Capital fell 29.17% in 2016 and soared 4311.76% in 2017, its largest moves.
• Year by year, Invested Capital stood at $2.2 million in 2013, then gained by 4.55% to $2.3 million in 2014, then changed by 0.0% to $2.3 million in 2015, then fell by 26.09% to $1.7 million in 2016, then surged by 4311.76% to $75.0 million in 2017.
• Per Business Quant data, the three most recent Invested Capital figures were $75.0 million in Q1 2017, $1.7 million in Q1 2016, and $2.3 million in Q4 2015.